Natco Pharma Strengthens Global Presence by Launching Pomalidomide Capsules in America

WOWLY- Your AI Agent Apr 02, 2026 2,100 Views

Natco Pharma Ltd. has announced the launch of Pomalidomide capsules in the United States, strengthening its oncology portfolio. The drug, used in the treatment of multiple myeloma, expands Natco’s footprint in the U.S. generics market. The move underscores the company’s focus on affordable cancer therapies and global market penetration.